Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, (190), 62-6

Clinical Assessment and Management of Spasticity: A Review

Affiliations
Review

Clinical Assessment and Management of Spasticity: A Review

T Rekand. Acta Neurol Scand Suppl.

Abstract

Spasticity is a sign of upper motor neurone lesion, which can be located in the cerebrum or the spinal cord, and be caused by stroke, multiple sclerosis, spinal cord injury, brain injury, cerebral paresis, or other neurological conditions. Management is dependent on clinical assessment. Positive and negative effects of spasticity should be considered. Ashworth score and the modified Ashworth score are the most used scales for assessment of spasticity. These and other spasticity scales are based on assessment of resistance during passive movement. The main goal of management is functional improvement. A novel 100-point score to assess disability, function related to spasticity (Rekand disability and spasticity score) is proposed. Management of spasticity should be multimodal and should always include physiotherapy or exercise. Oral medications such as baclofen and tizanidine have limited efficacy and considerable side effects, but are easiest to use. Botulinum toxin combined with physiotherapy and/or orthopaedic surgery is effective treatment of localized spasticity. Treatment with intrathecal baclofen via programmable implanted pump is effective in generalized spasticity, particularly in the lower extremities. Neurosurgical and orthopaedic procedures may be considered in intractable cases.

Similar articles

  • Spasticity Following Spinal Cord Injury
    T Rekand et al. Tidsskr Nor Laegeforen 132 (8), 970-3. PMID 22562332. - Review
    Spasticity may be general, regional or localised. Factors such as an over-filled bladder, obstipation, acute infections, syringomyelia or bone fractures may substantially …
  • [Botulinum Toxin Treatment of Hip Adductor Spasticity in Multiple Sclerosis]
    J Wissel et al. Wien Klin Wochenschr 113 Suppl 4, 20-4. PMID 15506048. - Review
    Spasticity results in a resistance to passive movement and decrease of passive mobility of the involved joints and is defined as a state of hypertonicity with exaggeratio …
  • The Guidelines for the Diagnosis and Treatment of Spasticity
    I Dones et al. J Neurosurg Sci 50 (4), 101-5. PMID 17108887.
    Spasticity is a predominant clinical sign appearing in different neurological diseases. It is always flanked by various degrees of muscle weakness. The clinical evaluatio …
  • Management of Spasticity Revisited
    LA Graham. Age Ageing 42 (4), 435-41. PMID 23775030. - Review
    Spasticity is common after stroke and other neurological conditions and causes considerable limitations of movement, activities of daily living and participation. Interac …
  • Spasticity: Pathophysiology, Evaluation and Management
    A Kheder et al. Pract Neurol 12 (5), 289-98. PMID 22976059. - Review
    Spasticity is common in many neurological disorders, such as stroke and multiple sclerosis. It is part of the upper motor neurone syndrome manifesting as increased tone, …
See all similar articles

Cited by 19 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback